Learn about the signs and symptoms of HIV. This article looks at the symptoms of the HIV and AIDS, and how they change over the different stages.
Source: HIV/AIDS news from Medical News Today
Monat: Juni 2016
TSRI scientists stabilize HIV structure, design potential AIDS vaccine candidates
Two new studies led by scientists at The Scripps Research Institute advance efforts to produce HIV vaccine candidates, potentially suitable for large-scale production.Want to catch a criminal?
Source: HIV/AIDS news from Medical News Today
Could mimicking infants' immune response produce a faster-acting HIV vaccine?
A study that examines how babies‘ immune systems produce antibodies to HIV-1 could offer a roadmap to development of a faster-acting vaccine.
Source: HIV/AIDS news from Medical News Today
Strengthening immune defence may be solution for treating tuberculosis
Researchers at Linköping University have made a discovery that could contribute to developing new vaccines and treatment alternatives for tuberculosis in the future.
Source: HIV/AIDS news from Medical News Today
HIV entry mechanism into immune cell nucleus revealed
How does HIV enter the nucleus of immune cells when it is bigger than the pores in its walls? New research shows it hijacks a protein to enlarge the pores.
Source: HIV/AIDS news from Medical News Today
Study observes potential breakthrough in treatment of HIV
A new study conducted by researchers at the San Francisco VA Medical Center (SFVAMC) observes that pharmacological enhancement of the immune systems of HIV patients could help eliminate infected…
Source: HIV/AIDS news from Medical News Today
Transgender rights critical for the health of 25 million transgender people worldwide
Public health efforts fail to capture even most basic information about transgender health, but social, legal context in which many transgender people live has led to high rates of HIV, depression.
Source: HIV/AIDS news from Medical News Today
Topical application of antiretroviral drug combination prevents transmission of (S)HIV
2 powerful AVR drugs provide complete protection for over 4 months.Researchers are edging ever closer to discovering the perfect combination of drugs and drug delivery system that will stop the…
Source: HIV/AIDS news from Medical News Today
Autologous stem cell transplantation offers safe and effective – and potentially curative – option for patients with HIV-associated lymphoma
Multicenter, Phase II trial suggests autologous transplant should be standard of care for HIV patients with relapsed/treatment-resistant lymphoma.
Source: HIV/AIDS news from Medical News Today
Candida-specific helper T cells are preferential and early targets of HIV
Candida yeasts normally live on human skin and mucous membranes without causing disease. In individuals with a weakened immune system, however, they are a major cause of opportunistic infections.
Source: HIV/AIDS news from Medical News Today